What initial norepinephrine (noradrenaline) infusion rate should be used for a 65‑year‑old, 70‑kg patient to achieve a mean arterial pressure of at least 65 mm Hg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Norepinephrine Infusion Rate for Septic Shock

For a 65-year-old, 70-kg patient requiring norepinephrine to achieve a MAP ≥65 mmHg, start at 0.02 µg/kg/min (approximately 1.4 µg/min or 0.5 mg/h), administered through central venous access after or concurrent with at least 30 mL/kg crystalloid resuscitation. 1, 2

Pre-Administration Requirements

Before initiating norepinephrine, you must address hypovolemia first:

  • Administer a minimum 30 mL/kg crystalloid bolus (2,100 mL for a 70-kg patient) within the first 3 hours, either before or simultaneously with vasopressor initiation 1, 2
  • Use balanced crystalloids (lactated Ringer's or Plasma-Lyte) preferentially over normal saline 2
  • Exception for profound hypotension: If systolic BP <70 mmHg or diastolic BP ≤40 mmHg, start norepinephrine emergently while fluid resuscitation continues rather than waiting for complete volume repletion 2

Specific Starting Dose

The most recent guidelines provide weight-based dosing:

  • Initial rate: 0.02 µg/kg/min 1, 2
  • For a 70-kg patient, this equals 1.4 µg/min or approximately 0.5 mg/h 2
  • Alternative guideline recommendation: 0.02–0.05 µg/kg/min (0.5 mg/h) 2

The FDA label provides concentration-based dosing that translates similarly:

  • Standard dilution: Add 4 mg norepinephrine to 1,000 mL D5W (yielding 4 µg/mL) 3
  • Initial infusion rate: 2–3 mL/min (8–12 µg/min of base) 3
  • Maintenance rate: 0.5–1 mL/min (2–4 µg/min of base) 3

Administration Route & Monitoring

Central venous access is strongly preferred to minimize extravasation risk and tissue necrosis 1, 2. However, if central access is unavailable:

  • Starting norepinephrine via a large peripheral vein is safe until central access is established 1
  • This approach reduces treatment delays in critically ill patients 1

Monitoring requirements:

  • Place an arterial catheter for continuous blood pressure monitoring as soon as practical 1, 2
  • Check blood pressure and heart rate every 5–15 minutes during initial titration 1, 2
  • Monitor urine output hourly (target ≥0.5 mL/kg/h) 2
  • Measure lactate levels every 2–4 hours during early resuscitation 2
  • Assess mental status, capillary refill, and peripheral perfusion regularly 2

Target Blood Pressure

Target MAP of 65 mmHg for most patients with septic shock 1, 2. This represents the minimum threshold for adequate organ perfusion.

Important nuances:

  • Patients with chronic hypertension may require a higher target of 70–75 mmHg to reduce the need for renal replacement therapy 1, 2
  • A recent UK study in patients >65 years showed that allowing MAP to drop to 60 mmHg resulted in no difference in 90-day mortality compared to targeting 65 mmHg 1
  • Do not target MAP >85 mmHg routinely—a multicenter trial found no mortality benefit (36.6% vs 34.0% at 28 days) and increased risk of arrhythmias 1

Titration Strategy

Titrate to both MAP and tissue perfusion markers:

  • Increase dose gradually based on hemodynamic response 2
  • Monitor lactate clearance, urine output, mental status, and capillary refill in addition to MAP 2
  • The typical maintenance range is 0.1–0.5 µg/kg/min 2

Escalation for Refractory Hypotension

If MAP ≥65 mmHg cannot be achieved with norepinephrine alone:

  1. Add vasopressin at 0.03 units/min when norepinephrine reaches 0.1–0.25 µg/kg/min 1, 2

    • Do not exceed 0.03–0.04 units/min for routine use 2
    • Vasopressin should never be used as monotherapy 2
  2. Add epinephrine 0.1–0.5 µg/kg/min as an alternative to vasopressin 2

  3. Add dobutamine 2.5–20 µg/kg/min if persistent hypoperfusion exists despite adequate MAP, particularly with myocardial dysfunction 1, 2

  4. Consider hydrocortisone 50 mg IV every 6 hours (or 200 mg/day continuous infusion) for refractory shock 1, 2

Critical Pitfalls to Avoid

  • Never use dopamine as first-line therapy—it is associated with 11% absolute increase in mortality and higher arrhythmia rates compared to norepinephrine 4
  • Do not use low-dose dopamine for renal protection—it provides no benefit 1, 5
  • Avoid phenylephrine as first-line agent—it may raise blood pressure while worsening tissue perfusion 5, 4
  • Do not delay norepinephrine while pursuing aggressive fluid resuscitation alone in severe hypotension 2
  • Do not mix norepinephrine with sodium bicarbonate or other alkaline solutions, as this inactivates the drug 5

Extravasation Management

If extravasation occurs:

  • Infiltrate phentolamine 5–10 mg diluted in 10–15 mL normal saline intradermally at the site immediately to prevent tissue necrosis 1, 5, 2

Special Considerations for This Patient

For a 65-year-old patient specifically:

  • The recent UK study suggests that in patients >65 years, targeting MAP 60–65 mmHg may be acceptable and reduces vasopressor exposure without increasing mortality 1
  • However, start with the standard target of 65 mmHg and individualize based on chronic hypertension status and tissue perfusion markers 1, 2
  • If the patient has a history of hypertension, consider targeting MAP 70–75 mmHg to reduce risk of acute kidney injury requiring renal replacement therapy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initiation and Management of Norepinephrine Infusion in Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Vasopressor Management in Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.